Stockholders' Equity (Tables)

3 Months Ended

Jun. 30, 2023

Stockholders Equity Note [Abstract]

Schedule of Stock-Based Compensation Expense

The following table summarizes total share-based compensation expense included in the condensed consolidated statements of net income and comprehensive income for the three months ended June 30, 2023 and 2022:

	Three Months Ended June 30,
	2023			2022
Costs and expenses:
Cost of revenue	$	842		$	563
Research and development costs		655			1,583
Selling, general and administrative		6,459			6,620
Total share-based compensation		7,956			8,766
Income tax benefit		(1,894	)		(2,045	)
Decrease in net income	$	6,062		$	6,721

Summary of Restricted Stock Awards Activity

Restricted stock awards activity during the three months ended June 30, 2023 is summarized as follows:

				Weighted-
				Average
				Grant-Date
	Number of			Fair Value
	Shares			per Share
Outstanding, March 31, 2023		3,297,512		$	16.72
Granted		1,307,856			15.49
Vested		(749,953	)		15.82
Canceled		(101,790	)		16.42
Outstanding, June 30, 2023		3,753,625		$	16.48

Summary of Stock Option Activity

The following table summarizes the stock option transactions during the three months ended June 30, 2023:

				Weighted-		Weighted-
				Average		Average		Aggregate
				Exercise		Remaining		Intrinsic
	Number of			Price		Contractual		Value
	Shares			per Share		Life (years)		(in thousands)
Outstanding, March 31, 2023		1,130,813		$	14.75		1.7	$	3,011
Exercised		(188,324	)		14.15		1.4	$	228
Forfeited/Canceled		(500	)		—
Expired		(4,700	)		16.64
Outstanding, June 30, 2023		937,289		$	14.86		1.8	$	1,342
Vested and expected to vest, June 30, 2023		937,289		$	14.86		1.8	$	1,342
Exercisable, June 30, 2023		937,289		$	14.86		1.8	$	1,342